Centogene has announced that the company has recieved US Food and Drug Administration (FDA) approval for the issuance of Emergency Use Authorization (EUA) for its proprietary SARS-CoV-2 RT-PCR test called the CentoSure. The EUA allows the administration of the test for individuals who are not suffering from any COVID-19 symptoms, and to accelerate testing worldwide.
OraSure Technologies has announced that its DNA Genotek subsidiary received EUA for the use of its OMNIgene® oral saliva collection device. The at-home test kit is the first FDA approved device that can be collected and safely used by individuals at home and without the presence of any healthcare professional or in a healthcare setting.
Thermo Fisher Scientific has announced that it has received authorisation for the expansion of its EUA for the TaqPath COVID-19 Combo Kit, along with a home sample collection kit by Everlywell, a digital health testing company. The combined kit allows individuals to collect nasal swabs samples when instructed by a healthcare provider and after receiving the results of a COVID-19 questionnaire.
Beroni Group has collaborated with GenScript Biotech Corporation for the successful completion of a SARS-CoV-2 pseudovirus neutralisation assay. The assay helps fight the virus by targeting Covid-specific nanobodies and testing their affinity and efficacy, to try an prevent future infections.